Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind study of BMS-986142 in rheumatoid arthritis with inadequate response to methotrexate
jRCT2080223262Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2016
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of BMS-986142 in rheumatoid arthritis (RA) (4 arms), sponsored by Bristol Myers Squibb. Started Jul 2016; status: completed.
02
Drugs
BMS-986142
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2080223262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223262.